Day: September 1, 2022

LONDON, Sept. 01, 2022 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in three upcoming investor events as follows:Citi 17th Annual BioPharma Conference: panel at 10:30 am ET on 7 September 2022 and host investor meetings Morgan Stanley 20th Annual Global Healthcare Conference: fireside chat at 11:45 am ET on 14 September 2022 and host investor meetings Cowen’s 2nd Annual Novel Mechanisms in Neuropsychiatry Summit: panel at 3:05 pm ET on September 19thA live audio webcast of each event will be accessible from the “Events” page of the Investors section of the COMPASS website. Each replay of the webcast will be accessible for 30 days following each event....

MIDLAND, Texas, Sept. 01, 2022 (GLOBE NEWSWIRE) — Permian Resources Corporation (“Permian Resources” or the “Company”) today announced the successful completion of the combination of Centennial Resource Development, Inc. (“Centennial”) (NASDAQ: CDEV) and Colgate Energy Partners III, LLC (“Colgate”). Permian Resources HighlightsLargest pure-play E&P company in the Delaware Basin Deep inventory of high-quality drilling locations on ~180,000 net acres Unique combination of attractive growth profile and robust shareholder returns framework Strong balance sheet protects the business and return of capital program across commodity price cycles Industry-leading shareholder alignment, with employee ownership exceeding 13% Management compensation highly weighted towards equity and performanceManagement Commentary “Permian Resources...

Biopharmaceutical Executive with More than 30 Years of Experience With Top Global Big Pharma Companies GSK and Bristol Myers Squibb TUSTIN, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced the appointment of Pramthesh (Prem) Patel, Ph.D., as vice president, process development for its mammalian cell business. Dr. Patel is an accomplished biopharmaceutical industry executive with more than 30 years of experience and a track record of success in developing manufacturing processes for clinical trial material and commercial supplies. His career is highlighted by extended...

NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES Philadelphia, PA, Sept. 01, 2022 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (the “Company” or “VSBLTY”) (CSE: VSBY) announces that further to its news releases dated July 26 and 28, 2022, it has closed the second tranche (the “Second Tranche”) of its previously announced non-brokered private placement (the “Private Placement”) of units (the “Units”). Units were previously sold in a first tranche of the Private Placement concurrently with and on the same terms as the Units issued and sold under the previously announced best efforts marketed public offering which closed on July 28, 2022 (the “Public Offering”). The Units were offered and sold under the Public Offering by way of a short form prospectus filed in the provinces of British Columbia,...

Bagsværd, Denmark and Watertown, Mass, US, 01 September 2022 – Novo Nordisk and Forma Therapeutics, Holdings Inc. (Nasdaq: FMTX) today announced that they have entered into a definitive agreement under which Novo Nordisk will acquire Forma Therapeutics for USD 20 per share in cash, which represents a total equity value of USD 1.1bn. Forma Therapeutics is a clinical-stage biopharmaceutical company focused on transforming the lives of patients with sickle cell disease (SCD) and rare blood disorders. The acquisition of Forma Therapeutics, including its lead development candidate, etavopivat, is aligned with Novo Nordisk’s strategy to complement and accelerate its scientific presence and pipeline in haemoglobinopathies, a group of disorders in which there is abnormal production or structure of the haemoglobin protein in the red blood cells. “Novo...

LOUISVILLE, Colo., Sept. 01, 2022 (GLOBE NEWSWIRE) — Solid Power, Inc. (“Solid Power”) (Nasdaq: SLDP), an industry-leading developer of all-solid-state battery cells for electric vehicles, today announced its participation in the upcoming Cowen 15th Annual Global Transportation & Sustainable Mobility Conference to be held September 7-9, 2022. Doug Campbell, Chief Executive Officer, will be presenting. Mr. Campbell and Kevin Paprzycki, Chief Financial Officer, will participate in small group meetings as part of the conference. Solid Power’s presentation at the Cowen 15th Annual Global Transportation & Sustainable Mobility Conference is scheduled for 10:40 a.m. – 11:10 a.m. ET on Friday, September 9, 2022. A live webcast link of the presentation can be accessed via the link provided below or by visiting the Events &...

Campaign achieved 21-35% incremental reach across key audience segments with the addition of linear addressable and higher conversion efficiency for linear addressable compared to OTT NEW YORK, Sept. 01, 2022 (GLOBE NEWSWIRE) — Magnite (NASDAQ: MGNI), the world’s largest independent omnichannel sell-side advertising platform, today announced that its programmatic addressable offering enabled Travel Texas to broaden their campaign footprint across key audience segments compared to OTT alone, driving overall incremental reach and growing their consumer pool by 21-35%. The results, measured in a cross-platform analysis by InnovidXP, also demonstrated a significantly higher conversion efficiency for linear addressable across Travel Texas’ key audience segments compared to CTV/OTT. “Working with Magnite has allowed us to reach our desired...

Innofactor Plc Annual Financial Report, on September 1, 2022, at 14:55 Finnish time On March 10, 2022, Innofactor published its Financial Statement in accordance with European Single Electronic Format (ESEF) reporting requirements with the format of the report being Extensible Hypertext Markup Language (XHTML). The notes to the Financial Statement, the parent company’s Financial Statement and the Report of the Board of Directors, which were not included in the original file, have now been added with XBRL tags. The updated XHTML file is available on www.innofactor.com/invest-in-us/releases-publications-and-reports/#annual-reports. Espoo, September 1, 2022 INNOFACTOR PLC Sami Ensio, CEO Additional information:Sami Ensio, CEOInnofactor PlcTel. +358 50 584 2029sami.ensio@innofactor.com Distribution:NASDAQ HelsinkiMain mediawww.innofactor.com Innofactor Innofactor...

LONDON, Ontario, Sept. 01, 2022 (GLOBE NEWSWIRE) — Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/ XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeutics, today announced that it has completed the second and final tranche of its previously announced private placement with Evotec SE (FSE:EVT) (NASDAQ: EVO) of 2,709,800 common shares of the Company (“Common Shares”) at a price of $2.50 per share for total proceeds of $6,774,500. Upon completion of the second tranche, Evotec’s strategic investment in Sernova totals $27,098,000. “Evotec’s investment at $2.50 per share, significantly more than double yesterday’s closing price, reflects the value our strategic partner places on Sernova relative to the current trading price on the TSX,” commented Dr. Philip Toleikis, President and CEO of Sernova Corp. “The...